Hyperfractionated radiotherapy with or without misonidazole: Results of a prospective randomized study in stage III–IV squamous cell carcinoma of the head and neck
- 1 October 1984
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 10 (10) , 1845-1849
- https://doi.org/10.1016/0360-3016(84)90260-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus bcnu for treatment of malignant glioma after surgery; Preliminary results of an RTOG studyInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Hyperfractionated radiotherapy in advanced squamous cell carcinoma of the head and neckInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind studyEuropean Journal of Cancer and Clinical Oncology, 1983
- Misonidazole and radiotherapy in lung cancer: A randomized double-blind trialInternational Journal of Radiation Oncology*Biology*Physics, 1982
- A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytomaBritish Journal of Cancer, 1981
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Clinical testing of the radiosensitizer Ro 07-0582: Experience with multiple dosesBritish Journal of Cancer, 1977
- Radiosensitizing and Toxic Effects of the 2-Nitroimidazole Ro-07-0582 in Hypoxic Mammalian CellsRadiation Research, 1976
- Clinical testing of the radiosensitiser Ro-07-0582 I. dose tolerance, serum and tumour concentrationsClinical Radiology, 1976
- Hypoxic Sensitizers: Radiobiological Studies at the Cellular LevelRadiology, 1975